Researchers are testing an over-the-counter antihistamine that could treat multiple sclerosis (MS) in a breakthrough that could help 2.5 million people worldwide.Scientists from the University of , San Francisco, found that MS patients treated with clemastine, used to relieve fever and allergy symptoms, had a slight increase in myelin water in the brain, which indicates myelin repair.Dr Ari Green, medical director of the UCSF Multiple Sclerosis and Neuroinflammation Center and a Weill Institute for Neurosciences member, said: 'This is the first example of brain repair being documented on MRI for a chronic neurological condition.
Load More
Load More